Healthcare Services

Ankylosing Spondylitis Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Ankylosing Spondylitis Market From 2026 To 2030?

The ankylosing spondylitis market has recorded strong growth in recent years. It is expected to grow from $6.34 billion in 2025 to $6.85 billion in 2026, at a CAGR of 8.0%. This growth is supported by improved awareness and diagnosis, broader availability of NSAIDs and DMARDs, increased access to rheumatology specialists, expansion of hospital-based treatments, and greater use of imaging technologies for disease monitoring.

The ankylosing spondylitis market is expected to see strong growth, reaching $9.42 billion by 2030 at a CAGR of 8.3%. This growth is driven by increased adoption of biologics and biosimilars, a growing focus on personalized medicine, expansion of advanced biologic pipelines, rising demand for long-term disease management, and increased investment in autoimmune research. Major trends include wider use of biologic therapies, growing adoption of targeted DMARDs, increased emphasis on early diagnosis, expansion of personalized treatment strategies, and stronger integration of physical therapy programs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Ankylosing Spondylitis Market?

The rising occurrence of autoimmune diseases is expected to support the growth of the ankylosing spondylitis market going forward. Autoimmune diseases involve abnormal immune responses where the body attacks its own tissues, leading to inflammation and damage. Ankylosing spondylitis, a type of autoimmune arthritis affecting the spine and pelvis, develops due to a combination of genetic and environmental factors. For instance, in September 2023, the Impact of IBD Report 2023 by the IBD Clinical and Research Centre, a Canada-based organization, indicated that over 320,000 Canadians were living with inflammatory bowel disease (IBD) in 2023, with a prevalence of 825 per 100,000, projected to rise annually by 2.44% to reach 470,000 cases (1.1% of the population) by 2035. Thus, the increasing incidence of autoimmune diseases is driving the ankylosing spondylitis market.

Which Segments Are Included In The Analysis Of The Ankylosing Spondylitis Market?

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route Of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors

4) By Steroids: Oral Steroids, Injectable Steroids

5) By Physical Therapies: Physiotherapy, Exercise Programs

6) By Surgery: Joint Replacement Surgery, Spinal Surgery

Which Trends Are Impacting The Growth Of The Ankylosing Spondylitis Market?

Key companies in the ankylosing spondylitis market are focusing on advanced biologic treatments such as biosimilars to improve patient access, lower costs, and provide familiar treatment options. Biosimilars use established active ingredients from reference biologics while maintaining comparable safety and effectiveness. For instance, in August 2025, Amgen Biotechnology Singapore received approval for its biosimilar adalimumab (Amgevita) in 40 mg/0.4 mL autoinjector and 20 mg/0.2 mL prefilled syringe formats. This treatment is designed for adults with active ankylosing spondylitis who have not responded adequately to standard therapies, offering a cost-effective alternative with convenient administration.

Which Key Industry Participants Are Active In The Ankylosing Spondylitis Market?

Major companies operating in the ankylosing spondylitis market are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

Read the full ankylosing spondylitis market report here:

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

What Are The Leading Geographic Regions In The Ankylosing Spondylitis Market?

North America was the largest region in the ankylosing spondylitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ankylosing Spondylitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp

Browse Through More Reports Similar to the Global Ankylosing Spondylitis Market 2026, By The Business Research Company

Cervical Spondylosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/cervical-spondylosis-treatment-global-market-report

Axial Spondyloarthritis Axspa Global Market Report

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Osteoarthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795